1. Home
  2. PODD vs RGA Comparison

PODD vs RGA Comparison

Compare PODD & RGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • RGA
  • Stock Information
  • Founded
  • PODD 2000
  • RGA 1973
  • Country
  • PODD United States
  • RGA United States
  • Employees
  • PODD N/A
  • RGA N/A
  • Industry
  • PODD Medical/Dental Instruments
  • RGA Life Insurance
  • Sector
  • PODD Health Care
  • RGA Finance
  • Exchange
  • PODD Nasdaq
  • RGA Nasdaq
  • Market Cap
  • PODD 16.5B
  • RGA 14.1B
  • IPO Year
  • PODD 2007
  • RGA 1993
  • Fundamental
  • Price
  • PODD $275.81
  • RGA $223.23
  • Analyst Decision
  • PODD Buy
  • RGA Buy
  • Analyst Count
  • PODD 16
  • RGA 14
  • Target Price
  • PODD $271.19
  • RGA $228.79
  • AVG Volume (30 Days)
  • PODD 533.0K
  • RGA 446.2K
  • Earning Date
  • PODD 02-20-2025
  • RGA 02-06-2025
  • Dividend Yield
  • PODD N/A
  • RGA 1.60%
  • EPS Growth
  • PODD 235.68
  • RGA N/A
  • EPS
  • PODD 5.74
  • RGA 10.91
  • Revenue
  • PODD $1,983,900,000.00
  • RGA $21,873,000,000.00
  • Revenue This Year
  • PODD $23.56
  • RGA N/A
  • Revenue Next Year
  • PODD $18.07
  • RGA N/A
  • P/E Ratio
  • PODD $48.09
  • RGA $20.43
  • Revenue Growth
  • PODD 27.42
  • RGA 22.08
  • 52 Week Low
  • PODD $160.19
  • RGA $163.81
  • 52 Week High
  • PODD $279.77
  • RGA $233.81
  • Technical
  • Relative Strength Index (RSI)
  • PODD 61.05
  • RGA 59.27
  • Support Level
  • PODD $260.84
  • RGA $213.35
  • Resistance Level
  • PODD $274.45
  • RGA $223.28
  • Average True Range (ATR)
  • PODD 7.44
  • RGA 4.43
  • MACD
  • PODD 0.65
  • RGA 1.29
  • Stochastic Oscillator
  • PODD 88.34
  • RGA 86.41

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.

About RGA Reinsurance Group of America Incorporated

Reinsurance Group of America Inc is an insurance holding company with operations in the United States, Latin America, Canada, Europe, Africa, Asia, and Australia. The core products and services include life reinsurance, living benefits reinsurance, group reinsurance, health reinsurance, financial solutions, facultative underwriting, and product development. The company's operations are divided into traditional and financial solution businesses.

Share on Social Networks: